Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  MannKind Corporation    MNKD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

MannKind Corporation : MNKD, MU, ALXN and GMCR added to NASDAQ Active Stock Watch List at EPR

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/16/2013 | 03:05pm CET

New York, NY - (ACCESSWIRE) - 07/16/2013 - Equity Profile Report initiates its NASDAQ Active Stock Watch List adding MannKind Corp. (NASDAQ:MNKD), Micron Technology Inc. (NASDAQ:MU), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR),

MannKind Corp. (NASDAQ:MNKD) a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States closed up in its previous session (+6.47%) on 7,469,136 shares traded. MannKind Corp. (NASDAQ:MNKD) is currently up (+310.99%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about MannKind Corp. (NASDAQ:MNKD)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MNKD&SubId=AW

Micron Technology Inc. (NASDAQ:MU) a company that together with its subsidiaries, engages in manufacturing and marketing semiconductor devices worldwide closed up in its previous session (+2.99%) on 29,731,748 shares traded after Micron Technology Inc reported its Financials. Micron Technology Inc. (NASDAQ:MU) is currently up (+155.62%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Micron Technology Inc. (NASDAQ:MU)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MU&SubId=AW

Also mentioned in Equity Profile Report?s NASDAQ Active Stock Watch List and Investor Poll was: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR), Groupon, Inc. (NASDAQ:GRPN) and Zynga, Inc. (NASDAQ:ZNGA)

To see what other investors are saying about: ALXN, GMCR, GRPN, ZNGA

Click here: http://www.equityprofilereport.com/PR.aspx?stock=ALXN-GMCR-GRPN-ZNGA&SubId=AW

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:

Equity Profile Report

editor@Equityprofilereport.com


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MANNKIND CORPORATION
02/24 MANNKIND : Patent Issued for Apparatus and Method for Cryogranulating a Pharmace..
02/23 MANNKIND CORP : Completion of Acquisition or Disposition of Assets (form 8-K)
02/21 MANNKIND : Receives $16.7 Million From Sale of Valencia Property
02/21 MannKind Receives $16.7 Million From Sale of Valencia Property 
02/02 MANNKIND : Announces Launch of New Titration Pack and Field Force Expansion to A..
02/01 MANNKIND CORPORATION : Drug Approvals Expected to Rise as Trump Pledges to Speed..
02/01 MannKind Announces Launch of New Titration Pack and Field Force Expansion to ..
01/27 MannKind Corporation to Hold Investor Conference Call on February 1, 2017
01/12 MANNKIND CORP : Entry into a Material Definitive Agreement, Financial Statements..
01/11 MANNKIND CORPORATION (NASDAQ : MNKD) Files An 8-K Other Events
More news
Sector news : Bio Therapeutic Drugs
02/27DJSANOFI : Lonza to Invest CHF290 Million in New Plant in Switzerland
02/22 Genmab and J&J's cancer drug set for blockbuster sales this year
02/21 Icahn buys Bristol-Myers shares, adding to activist pressure
02/21DJBristol-Myers Expands Board, Boosts Buybacks Amid Activist Pressure
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
02/27 MANNKIND : Empty Saddles And Empty Promises
02/17 MannKind - Afrezza Sales Slip As New Sales Force Starts
02/16 INDUSTRY LEADERS : Relaxing FDA Standards Will Kill The Pharma Golden Goose
02/10 MannKind, Afrezza Sales, And 'Free Beer Tomorrow'
02/07 MannKind continues slump, shares down 2%
Advertisement
Financials ($)
Sales 2016 168 M
EBIT 2016 65,3 M
Net income 2016 52,5 M
Debt 2016 149 M
Yield 2016 -
P/E ratio 2016 4,61
P/E ratio 2017
Capi. / Sales 2016 2,39x
Capi. / Sales 2017 8,24x
Capitalization 254 M
More Financials
Chart MANNKIND CORPORATION
Duration : Period :
MannKind Corporation Technical Analysis Chart | MNKD | US56400P2011 | 4-Traders
Full-screen chart
Technical analysis trends MANNKIND CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 0,10 $
Spread / Average Target -81%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Matthew J. Pfeffer CEO, CFO, Director, VP & Head-Investor Relations
Kent Kresa Chairman
Raymond W. Urbanski Chief Medical Officer & Vice President
Joseph Kocinsky Chief Technology Officer & Vice President
Ronald J. Consiglio Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MANNKIND CORPORATION-17.89%250
AMGEN, INC.19.39%129 711
CELGENE CORPORATION2.14%94 741
GILEAD SCIENCES, INC.-1.58%92 881
REGENERON PHARMACEUTIC..1.62%39 573
ACTELION LTD22.36%28 883
More Results